Activity
-
I am beyond proud of the phenomenal team at LENZ Therapeutics and everything we have achieved to reach the incredible milestone of ringing the bell…
I am beyond proud of the phenomenal team at LENZ Therapeutics and everything we have achieved to reach the incredible milestone of ringing the bell…
Liked by Tiba Aynechi
-
I am excited to share my appointment as the CEO of @LatigoBiotherapeutics. I’m looking forward to working alongside the very talented Latigo…
I am excited to share my appointment as the CEO of @LatigoBiotherapeutics. I’m looking forward to working alongside the very talented Latigo…
Liked by Tiba Aynechi
-
Join us in welcoming Cristiana Guiducci, Ph.D., to Rezo as chief scientific officer! Dr. Guiducci brings a deep level of scientific expertise, with a…
Join us in welcoming Cristiana Guiducci, Ph.D., to Rezo as chief scientific officer! Dr. Guiducci brings a deep level of scientific expertise, with a…
Liked by Tiba Aynechi
More activity by Tiba
-
Our partner Kassandra Castillo has been named in both API Leaders of Influence and LGBTQ+ Leaders of Influence in the San Diego Business Journal. As…
Our partner Kassandra Castillo has been named in both API Leaders of Influence and LGBTQ+ Leaders of Influence in the San Diego Business Journal. As…
Liked by Tiba Aynechi
-
Great work by the Mirum (and Lumena) team! Two approvals for children with severe liver disease. Impressive and important
Great work by the Mirum (and Lumena) team! Two approvals for children with severe liver disease. Impressive and important
Liked by Tiba Aynechi
-
https://lnkd.in/gN9d64Yu Congrats to Zenas BioPharma on closing their Series C. Norwest Venture Partners is proud to be participating in this round…
https://lnkd.in/gN9d64Yu Congrats to Zenas BioPharma on closing their Series C. Norwest Venture Partners is proud to be participating in this round…
Shared by Tiba Aynechi
-
It was a pleasure to represent Novo Holdings as a co-lead investor in the Series A financing of Reunion Neuroscience. Congratulations to Natalie…
It was a pleasure to represent Novo Holdings as a co-lead investor in the Series A financing of Reunion Neuroscience. Congratulations to Natalie…
Liked by Tiba Aynechi
-
#ICYMI Our Scientific Co-Founder, Richard DiMarchi, Ph.D., was recently awarded the Mani L. Bhaumik 2023 Breakthrough of the Year Award from…
#ICYMI Our Scientific Co-Founder, Richard DiMarchi, Ph.D., was recently awarded the Mani L. Bhaumik 2023 Breakthrough of the Year Award from…
Liked by Tiba Aynechi
-
I am thrilled to share that the FDA has approved our therapy for children with relapsed or refractory #pLGG with a BRAF fusion or rearrangement, or…
I am thrilled to share that the FDA has approved our therapy for children with relapsed or refractory #pLGG with a BRAF fusion or rearrangement, or…
Liked by Tiba Aynechi
-
Proud to be part of the team at Norwest Venture Partners as we announce Fund 17 today! We're excited to continue partnering with visionary…
Proud to be part of the team at Norwest Venture Partners as we announce Fund 17 today! We're excited to continue partnering with visionary…
Liked by Tiba Aynechi
-
Big news from Norwest 🎉We’ve launched our $3 billion global fund, NVP 17, to continue partnering with visionary entrepreneurs and teams building the…
Big news from Norwest 🎉We’ve launched our $3 billion global fund, NVP 17, to continue partnering with visionary entrepreneurs and teams building the…
Shared by Tiba Aynechi
-
Today is a BIG day for Norwest. We’re celebrating the close of NVP Fund 17, our newest $3B venture and growth equity fund. Our team is looking…
Today is a BIG day for Norwest. We’re celebrating the close of NVP Fund 17, our newest $3B venture and growth equity fund. Our team is looking…
Shared by Tiba Aynechi
-
Here here! Many congrats to Roman Camarda and Alex Loftis, both of whom I’ve had the very good fortune of getting to know and work with during my…
Here here! Many congrats to Roman Camarda and Alex Loftis, both of whom I’ve had the very good fortune of getting to know and work with during my…
Liked by Tiba Aynechi
-
We are thrilled that our Scientific Co-Founder, Richard DiMarchi, Ph.D., will receive the prestigious 2023 Mani L. Bhaumik Breakthrough of the Year…
We are thrilled that our Scientific Co-Founder, Richard DiMarchi, Ph.D., will receive the prestigious 2023 Mani L. Bhaumik Breakthrough of the Year…
Liked by Tiba Aynechi
-
My team and I spend our days looking for healthcare companies with the potential to dramatically transform the lives of overlooked or unaddressed…
My team and I spend our days looking for healthcare companies with the potential to dramatically transform the lives of overlooked or unaddressed…
Liked by Tiba Aynechi
-
Yesterday was a banner day for Avalyn…. After a long process of designing a clinical study, getting feedback about it, raising money to fund it, and…
Yesterday was a banner day for Avalyn…. After a long process of designing a clinical study, getting feedback about it, raising money to fund it, and…
Liked by Tiba Aynechi
-
Excited to start a new chapter of Eliyan with the strong backing of $100M+ to date from our existing & new investors to turn our unique technologies…
Excited to start a new chapter of Eliyan with the strong backing of $100M+ to date from our existing & new investors to turn our unique technologies…
Liked by Tiba Aynechi
-
Engrail Therapeutics set out to raise $100 million for its Series B. Then a wave of deal activity happened in the neuroscience R&D sphere, and the…
Engrail Therapeutics set out to raise $100 million for its Series B. Then a wave of deal activity happened in the neuroscience R&D sphere, and the…
Liked by Tiba Aynechi
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More